[Federal Register Volume 64, Number 88 (Friday, May 7, 1999)]
[Notices]
[Page 24664]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 99-11316]
[[Page 24664]]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Food and Drug Administration
[Docket No. 99N-1075]
Public Health Impact of Vibrio Parahaemolyticus in Molluscan
Shellfish
AGENCY: Food and Drug Administration, HHS.
ACTION: Notice of public meeting.
-----------------------------------------------------------------------
SUMMARY: The Food and Drug Administration (FDA), Center for Food Safety
and Applied Nutrition, in conjunction with the Risk Assessment Working
Group of the National Advisory Committee on Microbiological Criteria
for Foods, in cooperation with the Food Safety and Inspection Service,
U.S. Department of Agriculture (FSIS/USDA) is announcing a public
meeting to discuss issues related to risk assessment models being
developed to examine the relationship between Vibrio parahaemolyticus
and human health.
DATE: The public meeting will be held on Wednesday, May 26, 1999, from
8 a.m. to 5 p.m. Submit written notices of participation by May 20,
1999. Written comments will be accepted until June 30, 1999.
ADDRESSES: The public meeting will be held at the Ambassador West
Hotel, 1300 North State Parkway, Chicago, IL. Submit registration and
written notices of participation to Catherine M. DeRoever (address
below). Submit written comments to the Dockets Management Branch (HFA-
305), Food and Drug Administration, 5630 Fishers Lane, rm. 1061,
Rockville, MD 20852. Two copies of any comments are to be submitted,
except that individuals may submit one copy. Comments are to be
identified with the docket number found in brackets in the heading of
this document.
FOR FURTHER INFORMATION CONTACT: Catherine M. DeRoever, Executive
Operations Staff (HFS-22), Center for Food Safety and Applied
Nutrition, Food and Drug Administration, 200 C St., SW., Washington, DC
20204, 202-205-4251, FAX 202-205-4970, or e-mail
cderoeve@bangate.fda.gov''.
Those persons interested in attending the public meeting should, by
May 20, 1999, fax their name, title, firm name, address, and telephone
number to Catherine M. DeRoever (fax number above).
Those persons interested in presenting information at the meeting
should, by May 20, 1999, fax their name, title, firm name, address,
telephone number, and an outline of their presentation to Catherine M.
DeRoever (fax number above).
There is no registration fee for this public meeting, but advance
registration is suggested. Interested persons are encouraged to
register early because space may be limited.
SUPPLEMENTARY INFORMATION: This public meeting will provide an
opportunity for an open discussion of the issues related to risk
assessment models under development that will be used to examine the
relationship between V. parahaemolyticus and human health.
The agenda will include presentations on such topics as: (1)
Introduction to the risk assessment, (2) preharvest and harvest, (3)
postharvest, (4) epidemiology of V. parahaemolyticus outbreaks, (5)
consumption patterns, and (6) characteristics of V. parahaemolyticus
dose-response.
The sponsoring agencies encourage individuals with relevant
scientific data or information, i.e., information concerning
preharvesting, harvesting and postharvesting, epidemiology, exposure,
and dose-response relationship of V. parahaemolyticus, to present such
information at the meeting or in written comments to this record.
A transcript of the public meeting will be prepared. Copies of the
transcript may be requested in writing from the Freedom of Information
Office (HFI-35), Food and Drug Administration, 5600 Fishers Lane, rm.
12A-16, Rockville, MD 20857, approximately 15 working days after the
meeting. The transcript of the public meeting and submitted comments
will be available for public examination at the Dockets Mnagement
Branch (address above) between 9 a.m. and 4 p.m., Monday through
Friday.
Dated: April 29, 1999.
William K. Hubbard,
Acting Deputy Commissioner for Policy.
[FR Doc. 99-11316 Filed 5-6-99; 8:45 am]
BILLING CODE 4160-01-F
